NIH-funded research R01 grant

Personalized digital help to cut drinking and improve HIV care

Official title: A Personalized Digital Intervention to Reduce Alcohol Use and Improve HIV Care Outcomes

Funded at University of Houston · NIH-11411040 · Data updated 2026-11-12

A patient-friendly digital program helps adults with HIV reduce hazardous alcohol use and boost adherence to HIV treatment.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Houston
NIH-funded
Lab location1 site (Houston, United States)
Project startAugust 10, 2026
Project endJuly 31, 2031
Funding year2026
Award (this year)$706,832
NIH project number1R01AA033300-01
Project IDNIH-11411040 on NIH RePORTER

Who could benefit from this research

Could help

Adults living with HIV who have hazardous alcohol use and are receiving or engaged in HIV care.

Less likely to help

Individuals without hazardous drinking or without active engagement in HIV care may see limited benefit.

What this research studies

This project offers a computer-delivered, personalized feedback program designed for people living with HIV who drink hazardously. It targets anxiety-related worries that can worsen drinking and emotional distress, with the goal of improving both alcohol behavior and HIV care outcomes. If you participate, you would complete online prompts and receive tailored feedback to reduce drinking and support staying on antiretroviral therapy. The approach builds on prior work showing the program can lower anxiety sensitivity and drinking, with potential benefits for health and daily functioning. The study aims to test this intervention within HIV care to see if it can be scaled to more patients who need integrated support.

Why it matters

Potential benefit: If successful, the program could help people with HIV drink less and stay adherent to their HIV treatment, improving overall health.

How similar studies have gone: Earlier versions of the intervention reduced anxiety sensitivity and drinking in at-risk groups and were feasible among people with HIV.

Where this research is happening

  • University of Houston
    Houston, United States
    Active

Researchers

  • Principal investigator: Garey, Lorra — University of Houston
  • Study coordinator: Garey, Lorra

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.